Chris Ogden

Chris Ogden's Title

Chris Ogden is the Senior Vice President (SVP) of Finance and Accounting at CytomX. His role involves overseeing the financial health of the company, ensuring robust accounting practices, and providing strategic financial guidance. Joining CytomX in August of 2021, Chris brings a wealth of experience and expertise to his position, significantly contributing to the company's financial strategy and operations.

Chris Ogden's Company

Chris Ogden joined CytomX, a company dedicated to developing innovative therapies for cancer treatment, in August 2021. CytomX leverages its proprietary Probody® therapeutic technology to create novel, targeted therapeutics. As SVP of Finance and Accounting, Chris plays a critical role in managing the company’s financial operations, ensuring that CytomX can continue to advance its mission of transforming lives with innovative cancer treatments.

Chris Ogden's Experience

Before joining CytomX, Chris Ogden held significant financial leadership roles at Eli Lilly and Company for 16 years. His tenure at Eli Lilly included positions such as the chief financial officer of Lilly Diabetes and the chief financial officer and treasurer of Lilly del Caribe in Puerto Rico. His diverse roles spanned drug development, manufacturing, commercial operations, and investor relations, providing him with a comprehensive understanding of the pharmaceutical industry’s financial intricacies.

Chris Ogden's Education and Expertise

Chris Ogden earned his M.B.A. from Harvard Business School, one of the most prestigious business schools globally, which equipped him with advanced skills in leadership, finance, and strategic management. He also holds a B.A. in economics from Wabash College. This strong educational foundation, combined with his extensive experience in financial leadership roles, positions Chris as a highly knowledgeable and skilled executive in the field of finance and accounting.